156 related articles for article (PubMed ID: 36759402)
1. Categorization of patients with systemic lupus erythematosus using disease activity, patient-reported outcomes, and transcriptomic signatures.
Arcani R; Jouve E; Chiche L; Jourde-Chiche N
Clin Rheumatol; 2023 Jun; 42(6):1555-1563. PubMed ID: 36759402
[TBL] [Abstract][Full Text] [Related]
2. Using Clinical Characteristics and Patient-Reported Outcome Measures to Categorize Systemic Lupus Erythematosus Subtypes.
Rogers JL; Eudy AM; Pisetsky D; Criscione-Schreiber LG; Sun K; Doss J; Clowse MEB
Arthritis Care Res (Hoboken); 2021 Mar; 73(3):386-393. PubMed ID: 31909888
[TBL] [Abstract][Full Text] [Related]
3. Interferon Inhibition for Lupus with Anifrolumab: Critical Appraisal of the Evidence Leading to FDA Approval.
Loncharich MF; Anderson CW
ACR Open Rheumatol; 2022 Jun; 4(6):486-491. PubMed ID: 35157371
[TBL] [Abstract][Full Text] [Related]
4. Changes in quality of life in relation to disease activity in systemic lupus erythematosus: post-hoc analysis of the BLISS-52 Trial.
Jolly M; Annapureddy N; Arnaud L; Devilliers H
Lupus; 2019 Dec; 28(14):1628-1639. PubMed ID: 31674267
[TBL] [Abstract][Full Text] [Related]
5. The use of patient-reported outcome measures to classify type 1 and 2 systemic lupus erythematosus activity.
Eudy AM; Reeve BB; Coles T; Lin L; Rogers JL; Pisetsky DS; Criscione-Schreiber LG; Doss J; Sadun R; Sun K; Clowse ME
Lupus; 2022 May; 31(6):697-705. PubMed ID: 35343853
[TBL] [Abstract][Full Text] [Related]
6. Paradoxical association between blood modular interferon signatures and quality of life in patients with systemic lupus erythematosus.
Seguier J; Jouve E; Bobot M; Whalen E; Dussol B; Gentile S; Burtey S; Halfon P; Retornaz F; Chaussabel D; Chiche L; Jourde-Chiche N
Rheumatology (Oxford); 2020 Aug; 59(8):1975-1983. PubMed ID: 31776548
[TBL] [Abstract][Full Text] [Related]
7. The Chinese version of the SLEQOL is a reliable assessment of health-related quality of life in Han Chinese patients with systemic lupus erythematosus.
Jiang HZ; Lin ZG; Li HJ; -Du Q; -Tian W; Wang SY; Guan SQ; Mei YF
Clin Rheumatol; 2018 Jan; 37(1):151-160. PubMed ID: 29168029
[TBL] [Abstract][Full Text] [Related]
8. Outcome measures to be used in clinical trials in systemic lupus erythematosus.
Strand V; Gladman D; Isenberg D; Petri M; Smolen J; Tugwell P
J Rheumatol; 1999 Feb; 26(2):490-7. PubMed ID: 9972993
[TBL] [Abstract][Full Text] [Related]
9. An exploration of patient-reported symptoms in systemic lupus erythematosus and the relationship to health-related quality of life.
Pettersson S; Lövgren M; Eriksson LE; Moberg C; Svenungsson E; Gunnarsson I; Welin Henriksson E
Scand J Rheumatol; 2012 Oct; 41(5):383-90. PubMed ID: 22646821
[TBL] [Abstract][Full Text] [Related]
10. Impact of disease activity on health-related quality of life in systemic lupus erythematosus - a cross-sectional analysis of the Swiss Systemic Lupus Erythematosus Cohort Study (SSCS).
Chaigne B; Chizzolini C; Perneger T; Trendelenburg M; Huynh-Do U; Dayer E; Stoll T; von Kempis J; Ribi C;
BMC Immunol; 2017 Mar; 18(1):17. PubMed ID: 28351341
[TBL] [Abstract][Full Text] [Related]
11. Cross-cultural validation of a disease-specific patient-reported outcome measure for systemic lupus erythematosus in Canada.
Bourré-Tessier J; Clarke AE; Mikolaitis-Preuss RA; Kosinski M; Bernatsky S; Block JA; Jolly M
J Rheumatol; 2013 Aug; 40(8):1327-33. PubMed ID: 23772082
[TBL] [Abstract][Full Text] [Related]
12. Validation and verification of the Japanese version of the systemic lupus erythematosus symptom checklist for patient quality of life.
Doi H; Ohmura K; Tabuchi Y; Hashimoto M; Takase Y; Inaba R; Kozuki T; Iwasaki T; Taniguchi M; Kitagori K; Akizuki S; Murakami K; Nakashima R; Yoshifuji H; Yamamoto W; Tanaka M; Akio M
Lupus; 2021 Jun; 30(7):1108-1115. PubMed ID: 33779381
[TBL] [Abstract][Full Text] [Related]
13. Validity of systemic lupus erythematosus disease activity score (SLE-DAS) for definition of lupus low disease activity state (LLDAS).
Abdelhady EI; Rabie M; Hassan RA
Clin Rheumatol; 2021 Nov; 40(11):4553-4558. PubMed ID: 34142298
[TBL] [Abstract][Full Text] [Related]
14. Impact of fatigue on health-related quality of life and illness perception in a monocentric cohort of patients with systemic lupus erythematosus.
Elefante E; Tani C; Stagnaro C; Ferro F; Parma A; Carli L; Signorini V; Zucchi D; Peta U; Santoni A; Raffaelli L; Mosca M
RMD Open; 2020 Feb; 6(1):. PubMed ID: 32075876
[TBL] [Abstract][Full Text] [Related]
15. The Fatigue Assessment Scale as a simple and reliable tool in systemic lupus erythematosus: a cross-sectional study.
Horisberger A; Courvoisier D; Ribi C
Arthritis Res Ther; 2019 Mar; 21(1):80. PubMed ID: 30909957
[TBL] [Abstract][Full Text] [Related]
16. High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus.
Oke V; Gunnarsson I; Dorschner J; Eketjäll S; Zickert A; Niewold TB; Svenungsson E
Arthritis Res Ther; 2019 Apr; 21(1):107. PubMed ID: 31036046
[TBL] [Abstract][Full Text] [Related]
17. Can disease specific measures for systemic lupus erythematosus predict patients health related quality of life?
Jolly M; Utset TO
Lupus; 2004; 13(12):924-6. PubMed ID: 15645747
[TBL] [Abstract][Full Text] [Related]
18. Comparisons of SLE-DAS and SLEDAI-2K and classification of disease activity based on the SLE-DAS with reference to patient-reported outcomes.
Onishi A; Tsuji H; Takase Y; Nakakubo Y; Iwasaki T; Kozuki T; Yoshida T; Shirakashi M; Onizawa H; Hiwa R; Kitagori K; Akizuki S; Nakashima R; Yoshifuji H; Tanaka M; Morinobu A
Rheumatology (Oxford); 2023 Dec; 62(12):3909-3915. PubMed ID: 36943365
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the Sensitivity to Change of the 36-Item Short Form Health Survey and the Lupus Quality of Life Measure Using Various Definitions of Minimum Clinically Important Differences in Patients With Active Systemic Lupus Erythematosus.
Nantes SG; Strand V; Su J; Touma Z
Arthritis Care Res (Hoboken); 2018 Jan; 70(1):125-133. PubMed ID: 28320078
[TBL] [Abstract][Full Text] [Related]
20. Fatigue in systemic lupus erythematosus : Association with disease activity, quality of life and psychosocial factors.
Yilmaz-Oner S; Ilhan B; Can M; Alibaz-Oner F; Polat-Korkmaz O; Ozen G; Mumcu G; Kremers HM; Tuglular S; Direskeneli H
Z Rheumatol; 2017 Dec; 76(10):913-919. PubMed ID: 27600110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
